| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Britthaven is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Britthaven is based in Kinston, NC. You can find more information on Britthaven at www.britthaven.com
Sunesis Pharmaceuticals, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Sunesis Pharmaceuticals, Inc. is based in South San Francisco, CA. You can find more information on Sunesis Pharmaceuticals, Inc. at www.sunesis.com
Today, Dynex designs and manufactures a full range of automated workstations, laboratory instruments, and associated consumables that enable scientists and clinicians to make breakthrough discoveries, earlier, more-accurate diagnoses - innovations to
Osceola Regional Medical Center is a Kissimmee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.